Tsumura Full Year 2024 Earnings EPS Beats Expectations, Revenues Lag - Simply Wall St
| TSUA Stock | EUR 23.60 0.00 0.00% |
Slightly above 56% of Tsumura's investor base is looking to short. The analysis of current outlook of investing in Tsumura Co suggests that many traders are alarmed regarding Tsumura's prospects. Tsumura's investing sentiment can be driven by a variety of factors including economic data, Tsumura's earnings reports, geopolitical events, and overall market trends.
Tsumura |
Tsumura Full Year 2024 Earnings EPS Beats Expectations, Revenues Lag Simply Wall St
Read at news.google.com
 |
Tsumura Fundamental Analysis
We analyze Tsumura's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tsumura using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tsumura based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
Tsumura is rated third in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Tsumura Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tsumura stock to make a market-neutral strategy. Peer analysis of Tsumura could also be used in its relative valuation, which is a method of valuing Tsumura by comparing valuation metrics with similar companies.
Peers
Tsumura Related Equities
| LDZU | ASPEN PHARUNADR | 4.68 | ||||
| TSUA | Tsumura | 0.00 | ||||
| CJH | CanSino Biologics | 0.55 | ||||
| TKDA | Takeda Pharmaceutical | 0.81 | ||||
| 3KY | HANSOH PHARMAC | 0.93 | ||||
| GU5 | Guangzhou Baiyunshan | 0.93 | ||||
| MRK | Merck | 1.16 | ||||
| HPX | Hisamitsu Pharmaceutical | 1.59 | ||||
| 5EA | Elanco Animal | 1.60 |
Additional Tools for Tsumura Stock Analysis
When running Tsumura's price analysis, check to measure Tsumura's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tsumura is operating at the current time. Most of Tsumura's value examination focuses on studying past and present price action to predict the probability of Tsumura's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tsumura's price. Additionally, you may evaluate how the addition of Tsumura to your portfolios can decrease your overall portfolio volatility.